The Human Papillomavirus And Its Effects On The United States

In June 2006, Gardasil, a Human Papillomavirus vaccine made by Merck & Co., was licensed for use and brought to the market (“HPV Vaccine”). Gardasil, which is given into a series of three injections, targets the main types of HPV. The types targeted are HPV 6, HPV 11, HPV 16 and HPV 18, which cause ninety percent of the genital warts and are the leading causes of cervical cancer (“Cervical Cancer Symptoms, Causes, Treatments”). Brought to the attention by researchers “combined, those strains affect an estimated 3 million women in the U.S” (“HPV Vaccine”). Since HPV is so common in the United States, the makers of Gardasil are trying to get a law approved that will make the shots mandatory. In 2006,

The human papillomavirus (HPV) is a sexually transmitted disease (STD) that is very common throughout the United States and worldwide (World Health Organization (WHO), 2016). There are over 100 different forms of the virus with 13 of these types being capable of causing cancer (WHO, 2016). HPV can lead to the development of serious health problems. Theses health problems are especially an issue for adolescent women due to the highly increasing STD rates among this age group (Kostas-Polston, Johnson-Mallard & Berman, 2012). There is a vaccine for many of the common types of HPV, however, many parents are refusing to vaccinate their daughters for various reasons. With the rising cases of STDs, less birth

Unfortunately, there is not a vaccination to protect against every type of cancer. However, the Gardasil vaccine guards against certain strands of HPV that cause 70% of cervical cancers in women. When caught early, the Human papillomavirus is treatable, but after the virus has developed into cancer, there is no cure. Therefore, the person affected begins a painful, uncertain journey to try to save her life. The Encyclopedia of Women’s Health states, “Human papillomavirus (HPV) infection may be the most common viral sexually transmitted disease (STD) in this country. As many as 30 million Americans are infected with HPV, and each year, an additional 1 million people become infected.” (“Human Papillomavirus”). When this many people are affected by a disease that can become cancer, it would be doltish not to use available resources to prevent it. “Nationally and internationally, the HPV vaccine will significantly

The HPV virus has gone unseen by many until the recent controversy over the vaccine. However, this virus is thought to be one of the world’s most wide spread STD’s. “According to the Centers for Disease Control and Prevention (CDC), about 6.2 million women and men are newly infected every year” with HPV. HPV has over 100 strains, with more than thirty that are sexually transmitted. Some of these strains are known to cause cervix, vulva, vagina, anus, or penis cancers and others can cause genital warts. “Studies have found the vaccine to be almost 100% effective in preventing diseases caused by the four HPV types covered by the vaccine—including precancers of the cervix, vulva and vagina, and genital warts” (“HPV Questions and

Prophylactic vaccination against high risk human papilloma virus 16 and 18 represents an exciting means of protection against HPV related malignancy. However, this strategy alone, even if there is a level of cross protection against other oncogenic viruses, cannot completely prevent cervical cancer. In some countries cervical screening programs have reduced the incidence of invasive cervical cancer by up to 80 percent although this decline has now reached a plateau with current cancers occurring in patients who have failed to attend for screening or where the sensitivity of the tests have proved inadequate. Cervical screening is inevitably associated with significant anxiety for the many women who require investigation and treatment following abnormal cervical cytology. However, it is vitally important to stress the need for continued cervical screening to complement vaccination in order to optimize prevention in vaccines and prevent cervical cancer in older women where the value of vaccination is currently unclear. It is likely that vaccination will ultimately change the natural history of HPV disease by reducing the influence of the highly oncogenic types HPV 16 and 18. In the long term this is likely to lead to an increase in recommended screening intervals. HPV vaccination may also reduce

The authors appreciated the fact that Canada recently approved the use of the vaccine for males, which should decrease cervical, penile, and anal cancer rates and help in cost-savings. Unfortunately, the awareness of the new HPV vaccines remains low despite its efficacy and a small number of adverse

Almost all cervical carcinomas are caused by Human papillomavirus (HPV). Cervical cancer can be a life-threating disease. However, over recent years the occurrence of cervical cancer has declined as well as the chance of dying from it. A huge contributing factor to this decline is the importance of a regular pap smear. A pap smear can find cervical pre-cancer before it turns into cancer. Recently, a vaccine for HPV, has been on the market, which provides close to a 100% protection against pre-cancer and general warts. HPV and cervical cancer are two disease that are closely related. However, each disease effects not only similar populations, but also different populations, as well as having its own signs and symptoms, detection procedures,

Human Papillomavirus(HPV) is the most common sexually transmitted infection in the United States, according to Centers for Disease Control and Prevention(CDC) around 20 million people are infected with HPV and additional 6.2 million people are newly infected every year. According to National Health and Nutrition Examination Survey in 2003-2004 among sexually active women (57% of 14 to 19 years and 97% of 20 to 59 years) HPV was highest prevalent in youngest age group (40% of 14-19 years and 50% of 20-24 years). Infection rates decrease after age of 24 years. There are more than 100 types of HPV viruses out of which 40 cause genital infections. Out of

Human Papillomavirus is a highly contagious sexually transmitted disease that is believed to be the precursor of several cancers, especially cervical cancer. Researchers have developed a couple of vaccines believed to prevent several strains of the virus. Much controversy has surrounded the birth of this vaccine because law makers want to make the vaccine mandatory for school -aged children. The public is outraged and therefore the controversy regarding the use of the vaccine is growing. However, there are many studies showing that the vaccine is safe to use and that it has been effective in lowering the rate of cervical cancer. The goal of this paper is to discuss different viewpoints in regards to the vaccine.

Human papillomavirus (HPV) is the most common sexually transmitted disease (STD) and can affect many sexually active individuals throughout their lifetimes and is spread through anal, oral and vaginal sex (CDC, 2016). HPV currently affects 79 million Americans with 14 million new cases of infection every year and is so pervasive most sexually-active individuals will encounter some form of the virus during their lives (CDC, 2016). HPV can be troublesome to detect as symptoms can develop years after initial infection or may not be seen at all, but in many cases HPV does not cause lasting health problems (CDC, 2016).

Cases show that over 4,000 people die from a cancer caused by HPV every year. This HPV vaccine is virtually 100% effective in preventing the lesions, which in turn prevents most cervical cancers caused by HPV. This vaccine is said to mirror the Hepatitis B vaccine which can last up to thirty years! The vaccine is also very safe. Case studies have been done on over one million women, and no one has come through with any side effects. This vaccine doesn’t prevent you from all sexually transmitted diseases, and it also isn’t sure to prevent you from all types of Human Papillomaviruses, just the ones that are more likely to cause cervical

The Human Papillomavirus (HPV) is a common sexually transmitted disease that infects the ano-genital tract of both males and females (Rubin, Kuttab, Rihani, & Reutzel, 2012, p. 1145). “A substantial burden of cancers and anogenital warts are attributable to HPV in the United States: in 2009, an estimated 34,788 new HPV-associated cancers and approximately 355,000 new cases of anogenital warts were associated with HPV infection” (CDC, 2015). The Gardasil quadrivalent vaccine was created to prevent the transmission of HPV. This vaccination is usually administered to adolescents between 11-12 years old and is a three dose series given over the course of six months. As a result of the extended vaccine period many patients are not completing the

Human Papillomavirus (HPV) is a sexually transmitted virus that spreads from person to person by direct contact of infected tissue. According to the CDC, nearly all men and women will contract HPV at some point in their life (Centers for Disease Control and Prevention [CDC], 2013). HPV can cause cervical, vaginal and vulvar cancers in females. HPV can also cause anal, throat, and neck cancer in both males and females. HPV is also known to cause genital warts in both males and females. According to the National Cancer Institute (2013), “approximately 12,340 new cases of cervical cancer will be diagnosed in the US, and 4,030 US women will die

Human Papilloma Virus (HPV) is the causative operator of cervical disease, which is a standout amongst the most unmistakable tumors in ladies. HPV is a sexually transmitted malady that can influence both men and ladies. The immunizer discovery systems uncovered that the greater part of the ladies (those that are sexually dynamic) worldwide and roughly 70% of the sexually dynamic ladies of US populace have been presented to the papilloma infection sooner or later in time. The African area is having the most astounding rate of commonness with an expected number of 379153 cases amid the year 2000.

The Human papillomavirus (HPV) is the virus responsible for cervical cancer. It is one the most common viral sexually transmitted infections. A vaccine was approved in 2006 that is effective in preventing the types of HPV responsible for 70% of cervical cancers and 90% of genital warts. Proposals for routine and mandatory HPV vaccination of girls have become sources of controversy for parents of school-aged youth, legislators, members of the medical community, and the public at large (Cooper et al. 2010).